Table 2.
Decision rules for the definition of risk-sharing arrangements
Uncertainty type | Objectives | Proposed model |
---|---|---|
Uncertainty concerning health outcomes | Limit and share the risk over short-term, medium-term, and long-term health outcomes | PBRSA (e.g., PLRS or coverage with evidence development) |
Uncertainty concerning financial outcomes | Limit and share the risk of unexpected growth of estimated BI due to variations in posology or treatment duration | CSA (e.g., price volume, budget and/or utilization capping) or conventional payment with simple discount based on clinical outcomes |
Limit and share the risk of unexpected growth of estimated BI due to unforeseen use extensions and the patient population | CSA (e.g., price volume, budget or/and utilization capping), conventional payment with simple discount based on clinical outcomes and/or access restriction concerning patient subgroups |
BI budgetary impact, CSA cost-sharing arrangement, PLRS performance-linked reimbursement scheme, PBRSA performance-based risk-sharing arrangement